Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Client Alert: AAA Introduces AI-Assisted Arbitrator for Certain Disputes

Client Alert

The American Arbitration Association (“AAA”) recently introduced an AI-assisted arbitration platform known as the “AI Arbitrator.” The technology is designed to help streamline arbitration, particularly in two-party, documents-only construction disputes, by using artificial intelligence to analyze filings, summarize evidence, and generate draft decisions for a human arbitrator to review.

Under the AAA’s framework, AI does not replace the arbitrator; rather, it assists with reviewing submissions, identifying claims and issues, summarizing evidence, and preparing a proposed award. A human AAA arbitrator reviews, revises if necessary, and ultimately issues the final binding decision.

The platform reflects a broader effort within the ADR community to reduce costs and improve efficiency in high-volume disputes. Early AAA estimates suggest AI-assisted arbitration may resolve cases 20-25% faster and reduce costs by roughly 35% or more in certain document-based cases.

Potential Advantages

Organizations considering arbitration clauses that incorporate AI-assisted processes should evaluate several potential benefits:

  • Cost savings and efficiency: Automated analysis of pleadings and exhibits may significantly reduce the time required for case review and award drafting.
  • Faster dispute resolution: Streamlined workflows can shorten the time from filing to award in straightforward cases.
  • Improved analytical consistency: AI tools can systematically organize claims, evidence, and legal authorities, potentially improving clarity for arbitrators and parties.
  • Strategic insights before filing: AAA has also developed tools such as a “Resolution Simulator,” which can model how an arbitrator might analyze a dispute to help parties assess risk before initiating arbitration.

Potential Risks & Considerations

Despite these advantages, companies should carefully consider potential limitations before agreeing to AI-assisted arbitration:

  • Transparency concerns: Parties may not have full visibility into how AI analyzes issues or drafts its recommendations.
  • Reliance on emerging technology: AI systems may carry risks of bias, errors, or incomplete analysis if not carefully supervised.
  • Limited applicability: The current platform is designed primarily for documents-only disputes, meaning more complex matters involving live witness testimony may not be appropriate.
  • Contractual implications: Because the process is opt-in, arbitration clauses must specifically allow for AI-assisted arbitration if parties wish to use it.

Takeaway

AI-assisted arbitration represents a notable development in alternative dispute resolution. While it may offer meaningful efficiency and cost benefits – particularly for straightforward, document-based commercial disputes – companies should carefully consider whether the process aligns with their dispute resolution strategy, risk tolerance, and existing contractual provisions before electing to use it.

If you have questions about incorporating AI-assisted arbitration into dispute resolution clauses or evaluating its use in a pending dispute, please contact BMD Partner Krista Osterfeld at kwosterfeld@bmdllc.com.


Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.

Top Compliance Risks for Ohio Med-Spas in 2025

The Ohio Board of Pharmacy has increased inspections of med-spas holding Terminal Distributor of Dangerous Drugs (TDDD) licenses, with many facing enforcement actions in 2025. Common issues include purchasing from unlicensed distributors, improper drug storage, inadequate recordkeeping, and insufficient prescriber oversight. Understanding these risks and maintaining compliance can help protect your practice from penalties and license suspension.

Pre and Postnuptial Agreements | Necessary, Maybe, What Happened to Forever?

Both Florida and Ohio now allow clients to enter into a prenuptial or postnuptial agreement prior to marriage or after marriage (Ohio previously did not allow postnuptial agreements). Both documents have statutory guidelines that must be followed in terms of execution and financial disclosure.

DHS Ends All Employment Authorization Auto-Extensions

Effective October 30, 2025, DHS ends all automatic work authorization renewals. The 540-day extension applies only to renewals filed before this date, and there is no grace period for expired EADs filed on or after October 30. Employers must audit EADs, train staff, ensure I-9 compliance, and plan for work authorization gaps. Penalties for noncompliance can be severe.

CMS’s Rural Health Funding Announcement

CMS has announced a $50 billion Rural Health Transformation (RHT) Program to improve healthcare access, quality, and outcomes in rural communities. All states are eligible to apply for funding by November 5, 2025. Half of the funds will be distributed equally, with the remainder based on state-specific factors. The program supports evidence-based initiatives, workforce recruitment, and access to treatment services, with awards assessed annually